Comments

Drugs Made In America Acquisition Corp. - Rights Stock Price, Quotes and Forecasts

DMAARNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.1500

-0.00500-3.23%

At close: -

$0.1500

-0.00500-3.23%

Drugs Made In America Acquisition Corp. - Rights (DMAAR) Forecast

News Earnings Drugs Made In America Acquisition Corp. - Rights (DMAAR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Drugs Made In America Acquisition Corp. - Rights Stock Price, Quotes and Forecasts | NASDAQ:DMAAR | Benzinga

Explore Drugs Made In America Acquisition Corp. - Rights stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DMAAR.

Open	$0.15
Close	$0.15
Volume / Avg.	997.91K / 1.40M
Day Range	$0.14 - $0.15
52 Wk Range	0.15 - 0.17
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.15
Close	$0.15
Volume / Avg.	997.91K / 1.40M
Day Range	$0.14 - $0.15
52 Wk Range	0.15 - 0.17
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

About Drugs Made In America Acquisition Corp.

Sector

N/A

Industry

N/A

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Drugs Made In America Acquisition Corp. - Rights (DMAAR) stock?

You can purchase shares of Drugs Made In America Acquisition Corp. - Rights (NASDAQ:DMAAR) through any online brokerage.

View our list of the best stock brokerages

Who are Drugs Made In America Acquisition Corp. - Rights (DMAAR) competitors?

There are no as such competitors for Drugs Made In America Acquisition Corp. - Rights.

What is the forecast, or price target, for Drugs Made In America Acquisition Corp. - Rights (DMAAR) stock?

There is no analysis for Drugs Made In America Acquisition Corp. - Rights to provide a consensus price target.

What is the current price for Drugs Made In America Acquisition Corp. - Rights (DMAAR)?

The stock price for Drugs Made In America Acquisition Corp. - Rights (NASDAQ: DMAAR) is $0.15 last updated February 25, 2025 at 9:26 AM EST.

Does Drugs Made In America Acquisition Corp. - Rights (DMAAR) pay a dividend?

There are no upcoming dividends for Drugs Made In America Acquisition Corp. - Rights.

When is Drugs Made In America Acquisition Corp. - Rights (NASDAQ:DMAAR) reporting earnings?

Drugs Made In America Acquisition Corp. - Rights does not have any upcoming earnings scheduled.

Is Drugs Made In America Acquisition Corp. - Rights (DMAAR) going to split?

There is no upcoming split for Drugs Made In America Acquisition Corp. - Rights.